Needle Free Injection Market Research Report – Forecast to 2027

Global Needle Free Injection Market Research Report information: Product (Fillable) Technology (Jet-Based) Usability (Reusable), Type of Medication (Liquid-Based), Site of Delivery (Intra dermal), Application (Vaccination) End Users (Hospitals) – Forecast Till 2027

ID: MRFR/HC/4721-CR | June 2018 | Region: Global | 100 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Request a Free Sample

The global needle free injection market is anticipated to reach USD 25,057.4 million by 2023, as per a new detailed report by Market Research Future (MRFR). It is expected to exhibit a phenomenal CAGR during the assessment period (2018-2023). Prevalence of various chronic diseases is propelling the need for needle free injections. Rise in investments in the pharmaceutical sector and convenient use of these medical devices in home care is projected to drive market growth over the forecast period.

Needle free injections are syringes which deliver drugs through direct contact with the skin instead of a hypodermic needle. They can be used by children, adults, and patients with allergic conditions without any doctor supervision. It can prevent needle stick injuries, which is a common factor of disease transmission. Increasing incidence of diabetes is anticipated to induce market demand in the coming years. But high cost of these devices and cross-contamination risks can deter market growth.

Report Overview

This report allows the user to gain a deeper understanding of the ongoing events and trends in the global market for needle free injections. By correlating the historical data with key market dynamics, our analysts were able to make highly accurate projections in the report. MRFR’s report includes a thorough segmental analysis of the global needle free injection market segmented by product type, test type, end-user, and region with astute insights. This report has been prepared to assist industry participants in making informed decisions on growth strategies and operation management. Users will also come across drivers, trends, opportunities, and restraints which are likely to influence the growth of the market during the assessment period.

Segment Overview

By product type, the needle free injection market has been segmented into prefilled and fillable needle free injectors. By technology, the market is segmented into laser-powered, spring-based, and jet-based. By usability, the market is segmented into disposable and reusable needle free injectors.

By medication type, the market is segmented into projectile/depot-based, powder-based, and liquid-based needle free injectors. By site of delivery, intradermal, intramuscular, and subcutaneous are segments in the market. Oncology, vaccination, insulin delivery, and others are major market applications. Prime end-users include ambulatory surgical centers, homecare settings, hospitals and clinics, and others.

The segments and sub-segments covered in the report are analyzed under four major regions –Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA), with respective country-level market sizing. For the scope of research, the standard definition of the product/ service “needle free injection” is included in the report. The report discusses and interprets the current and future opportunities of the industry delivering an unbiased growth assessment.

Players Covered

CROSSJECT, Medical International Technology, Inc., National Medical Products Inc., INJEX Pharma GmBH, PenJet Corporation, Valeritas Holdings, Inc., Antares Pharma Inc., D'Antonio Consultants International, Inc., MIKA MEDICAL CO., PharmaJet, Inc., Endo Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., and European Pharma Group are prominent players in the needle free injection market.

The report offers comprehensive profiles on these market players and assesses their current standing in the needle free injection market. Company history coupled with annual turnover, segmental share, SWOT analysis, growth strategies, new product launches, M&A activities, and latest R&D initiatives are outlined in the report.

Research Methodology

Market Research Future (MRFR) uses a combination of primary and secondary research to compile market reports. Primary data is accumulated from interviewing industry stalwarts and secondary research is collated by studying white papers and annual reports of leading players. Our analysts use top-down and bottom-up approaches to validate the findings of the report. The report comprises news, current trends, and future prospects related to the market, all of which can provide a thorough understanding of the market to clients. Industry leaders can make accurate business decisions based on our insights.

Analysis Period

Base Year - 2017

Projection Period - From 2018 to 2023

Market Denomination - USD Million

Conversion Rate - Considered as per the respective financial years

Intended Audience

Government Research Institutes

Research and Development (R&D) Companies

Medical Devices Companies

Academic Institutes and Universities

For the scope of research, the report offers a comprehensive analysis of the global needle free injection market.

Product Type

Prefilled Needle Free Injectors

Fillable Needle Free Injectors

Technology

Laser-powered

Spring-based

Jet-based

Usability

Disposable Needle Free Injectors

Reusable Needle Free Injectors

Type of Medication

Liquid-based Needle Free Injectors

Powder-based Needle Free Injectors

Projectile/Depot-based Needle Free Injectors

Site of Delivery

Intradermal Injectors

Intramuscular Injectors

Subcutaneous Injectors

Application

Oncology

Vaccination

Insulin Delivery

Others

End-user

Ambulatory Surgical Centers

Hospitals & Clinics

Homecare Settings

Others

Region

Americas; North America and South America

Europe; Western Europe and Eastern Europe

Asia Pacific (APAC); Japan, China, India, South Korea, and Rest of Asia Pacific

Middle East & Africa (MEA); The Middle East and Africa

Global Needle Free Injection Market: Report Summary

The global needle free injection market is predicted to touch USD 25,057.4 million by 2023 from USD 10,377.7 million in 2016, expanding at an astounding CAGR of 15.8% during the forecast period (2018-2023). High prevalence of diabetes is the primary factor driving the market. According to the American Diabetes Association, nearly 9.4% of the population in the U.S. reportedly had diabetes. This could result in a large number of users preferring needle free medication owing to low pain levels and fewer chances of contamination. In addition, incidence of chronic diseases and allergies which require accurate doses of medication is another driving factor of the market.

The needle free injection market is segmented on the basis of product type, technology, usability, type of medication, site of delivery, application, and end-user. By product type, the global market for needle free injection is segmented into fillable and prefilled needle free injectors. The fillable needle free injector segment can reportedly gain a higher market share by 2023. This can be attributed to surge in healthcare expenses and demand for protection against needle stick injuries. Technologies include jet-based, spring-based, and laser-powered. Among these, the jet-based segment will command a higher market share till 2023 owing to its rapid delivery of medication. It can rapidly dispense the vaccine over a large area under the skin in less time.

By usability, the market is segmented into reusable and disposable. The reusable segment can touch a valuation of USD 16,445 million by 2023, at a 15.1% CAGR over the forecast period. By type of medication, the market is segmented into liquid-based, powder-based, and projectile/depot-based. The liquid-based segment is anticipated to capture a large market share by 2023 owing to its user-friendly mechanism. By site of delivery, the market is segmented into intradermal, intramuscular, and subcutaneous injectors. The intramuscular segment is touted to expand the fastest due to muscles being the fastest administration route for vaccination. The muscles absorb the vaccine rapidly and dispense it to the bloodstream, expediting the recovery of the patient.

Major applications include oncology, vaccine, insulin delivery, and others. The insulin delivery application can grow robustly owing to high numbers of diabetics requiring insulin shots. On the other hand, the vaccination segment is touted to grow rapidly owing to various government campaigns vouching for the benefits of vaccines. End-users comprise ambulatory surgical centers, hospital & clinics, homecare settings, and others. The hospital and clinics segment is anticipated to dominate the needle free injection market owing to rising demand for painless solutions amid prevalence of cancer and other maladies.

Regional Market Summary

The global needle free injection market, by regions, is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).

The Americas accounted for 34.5% share of the market owing to constant technological advances in pharmaceutical and biotechnology sectors. Increasing demand for self-administering devices, prevalence of chronic diseases, and investments by players in the medical sector can propel its growth over the forecast period. Europe and APAC markets are anticipated to display steady growth rates respectively.

Competitive Analysis

The key players of the global needle free injection market include MIKA MEDICAL CO., PharmaJet, Inc., PenJet Corporation, Inovio Pharmaceuticals Inc., D'Antonio Consultants International, Inc., National Medical Products Inc., Valeritas Holdings, Inc., CROSSJECT, INJEX Pharma GmBH, Endo Pharmaceuticals Inc., Antares Pharma Inc., Medical International Technology, Inc., and European Pharma Group. Rising investments in pharmaceutical and biotechnology sectors can lead to further development in needle free injections.

1 Report Prologue

2 Market Introduction

2.1 Introduction 18

2.2 Assumptions & Limitations 18

3 Research Methodology

3.1 Research Process 21

3.2 Primary Research 21

3.3 Secondary Research 22

3.4 Market Size Estimation 22

4 Market Dynamics

4.1 Introduction 24

4.2 Drivers 24

4.2.1 Increasing Prevalence Of Chronic Conditions Such As Diabetes Is Estimated To Increase The Demand

For Needle-Free Injectors 24

4.2.2 Capacity Of Needle-Free Injectors To Support Homecare 24

4.2.3 Growing Biopharmaceuticals Industry 25

4.2.4 Increasing Investments In The Market 25

4.2.5 Drivers Impact Analysis 25

4.3 Restraints 26

4.3.1 Risks Of Cross Contamination 26

4.3.2 High Cost 26

4.3.3 Restraints Impact Analysis 26

4.4 Opportunity 27

4.4.1 Increasing Campaigns Of Vaccination In Developing Economies Of The Asia Pacific Region 27

4.5 Macroeconomic Indicators 27

5 Market Factor Analysis

5.1 Value Chain Analysis 29

5.1.1 R&D & Designing 29

5.1.2 Manufacturing 29

5.1.3 Distribution & Sales 29

5.1.4 Post-Sales Review 30

5.2 Porter’s Five Forces Model 31

5.2.1 Bargaining Power Of Suppliers 31

5.2.2 Bargaining Power Of Buyers 31

5.2.3 Threat Of New Entrants 32

5.2.4 Threat Of Substitutes 32

5.2.5 Intensity Of Rivalry 32

5.3 Investment Opportunities 32

5.4 Pricing Analysis 32

6 Needle Free Injection Market, By Product

6.1 Introduction 34

6.2 Fillable Needle-Free Injectors 35

6.3 Prefilled Needle-Free Injectors 35

7 Needle Free Injection Market, By Technology

7.1 Introduction 37

7.2 Jet-Based 38

7.3 Spring-Based 38

7.4 Laser-Powered 38

8 Global Needle Free Injection Market, By Usability

8.1 Introduction 40

8.2 Reusable Needle-Free Injectors 41

8.3 Disposable Needle-Free Injectors 41

9 Global Needle Free Injection Market, By Type Of Medication

9.1 Introduction 43

9.2 Liquid-Based Needle Free Injectors 44

9.3 Powder-Based Needle Free Injectors 44

9.4 Projectile/Depot-Based Needle Free Injectors 44

10 Needle Free Injection Market, By Site Of Delivery

10.1 Introduction 46

10.2 Intra Dermal Injectors 47

10.3 Intramuscular Injectors 47

10.4 Subcutaneous Injectors 47

11 Needle Free Injection Market, By Application

11.1 Introduction 49

11.2 Vaccination 50

11.3 Insulin Delivery 50

11.4 Oncology 50

12 Needle Free Injection Market, By End Users

12.1 Introduction 52

12.2 Hospitals And Clinics 53

12.3 Ambulatory Surgical Centres 53

12.4 Homecare Settings 53

13 Global Needle Free Injection Market, By Region

13.1 Introduction 55

13.2 Americas 56

Needle Free Injection Market, By Product

Needle Free Injection Market, By Technology